Carbonic Anhydrase IX As a Predictive Biomarker for Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Carbonic Anhydrase IX As a Predictive Biomarker for Clear Cell Renal Cell Carcinoma

Published:2008-06-20 Issue:18 Volume:26 Page:3105-3107
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pantuck Allan J.¹,Klatte Tobias¹,Seligson David²,Atkins Michael³,Belldegrun Arie¹

Affiliation:

1. Department of Urology, University of California, Los Angeles School of Medicine, Los Angeles, CA

2. Department of Pathology and Laboratory Medicine, University of California, Los Angeles School of Medicine, Los Angeles, CA

3. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.16.1935

Reference10 articles.

1. Carbonic Anhydrase IX Is Not an Independent Predictor of Outcome for Patients With Clear Cell Renal Cell Carcinoma

2. Bui MH, Seligson D, Han KR, et al: Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy. Clin Cancer Res 9:802,2003-811,

3. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma

4. Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

5. Klatte T, Zomorodian N, Kabbinavar FF, et al: Prospective evaluation of carbonic anhydrase IX (CAIX) as a molecular marker in metastatic renal cell carcinoma. J Clin Oncol 25:403s,2007, (suppl; abstr 4601)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of cell therapy for renal cell carcinoma;Molecular Cancer;2024-01-09

2. Combating challenges in CAR-T cells with engineering immunology;Frontiers in Cell and Developmental Biology;2022-10-10

3. A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma;Journal of Immunotherapy;2020-09-11

4. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma;Journal of Translational Medicine;2019-05-27

5. Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma;Scientific Reports;2017-10-27